Antylia Scientific?, a global leader in Bioprocessing and Life Science, with diverse portfolio of peristaltic, single-use solutions, lab instruments and consumables, diagnostic and environmental products for the pharma, healthcare, research and academic, environmental and industrial market segments, launches today.
Formerly Cole-Parmer Instrument Company, Antylia Scientific (An-til-e-a) will continue to build up our platform of unique products and expert customer support by expanding the company’s organic product research and development capabilities and acquiring complementary products and companies.
“Our evolution as a provider of mission critical products to our customers in their quest to discover and manufacture new therapeutics, vaccines, and diagnostic tests has led to creating Antylia Scientific,” said Bernd Brust, Chairman & CEO.
Antylia Scientific is creating two operating divisions, Bioprocessing and Life Sciences.
Antylia Scientific有兩大運營部門,分別是生物工藝和生命科學事業部。
Our bioprocessing portfolio includes our industry-leading Masterflex? I/P?, L/S?, B/T?, Ismatec? and Reglo range of peristaltic pumps, our MasterflexLive? connected products, pump and transfer tubing, flow meters and single-use components and assemblies. Masterflex addresses the entire fluid path from research to production with a solution set developed for the specific needs of our bioprocessing, pharma and food and beverage customers.
“Masterflex has become the industry standard. We are the customer’s first choice in peristaltic pumps that support their need for providing consistent, repeatable, reliable and pure end products in cGMP environments across the globe,” added Brian Barnett, SVP, Bioprocessing.
Our life sciences portfolio includes well-recognized brands such as the environmental sampling and testing innovator, Environmental Express?; real-time monitoring and cold storage expertise as Traceable?; our standards and external diagnostic control specialists, SPEX? and ZeptoMetrix?; and our lab essentials and consumables brand Cole-Parmer?.
“Innovation is in our DNA. Bringing together this portfolio of exceptional businesses, products and talent allows us to continue to deliver trailblazing products that improve the quality, accuracy, efficiency and repeatability of our customers’ critical processes,” said Jon Salkin, President, Antylia Scientific. “Antylia Scientific will serve as a catalyst for further organic investment and acquisitions in the burgeoning life sciences and environmental markets.”
“創新是我們的基因。將這一系列卓越的業務、產品和人才匯集在一起,使我們能夠繼續提供開創性產品,確保客戶關鍵流程對‘質量、準確性、效率和可重復性’的高要求。” Antylia Scientific總裁 Jon Salkin 說, “Antylia Scientific將成為推動生命科學和環境市場蓬勃發展,以及推動進一步投資和收購的催化劑。”
“With great respect for our company’s venerable history,” added Bernd Brust, “we are confident that Antylia Scientific is now well positioned to serve our customers in their quests to accelerate scientific discovery and improve the quality of life.”